1. Home
  2. BSVN vs NNNN Comparison

BSVN vs NNNN Comparison

Compare BSVN & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BSVN
  • NNNN
  • Stock Information
  • Founded
  • BSVN 2004
  • NNNN 2021
  • Country
  • BSVN United States
  • NNNN Germany
  • Employees
  • BSVN N/A
  • NNNN N/A
  • Industry
  • BSVN Major Banks
  • NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • BSVN Finance
  • NNNN Health Care
  • Exchange
  • BSVN Nasdaq
  • NNNN Nasdaq
  • Market Cap
  • BSVN 370.9M
  • NNNN 369.6M
  • IPO Year
  • BSVN 2018
  • NNNN 2025
  • Fundamental
  • Price
  • BSVN $43.95
  • NNNN $36.20
  • Analyst Decision
  • BSVN Buy
  • NNNN
  • Analyst Count
  • BSVN 2
  • NNNN 0
  • Target Price
  • BSVN $51.00
  • NNNN N/A
  • AVG Volume (30 Days)
  • BSVN 28.7K
  • NNNN 179.1K
  • Earning Date
  • BSVN 07-10-2025
  • NNNN 01-01-0001
  • Dividend Yield
  • BSVN 2.20%
  • NNNN N/A
  • EPS Growth
  • BSVN 46.15
  • NNNN N/A
  • EPS
  • BSVN 4.71
  • NNNN 0.06
  • Revenue
  • BSVN $96,026,000.00
  • NNNN $8,185,146.00
  • Revenue This Year
  • BSVN N/A
  • NNNN N/A
  • Revenue Next Year
  • BSVN $3.53
  • NNNN N/A
  • P/E Ratio
  • BSVN $9.25
  • NNNN $643.89
  • Revenue Growth
  • BSVN 28.97
  • NNNN 21.95
  • 52 Week Low
  • BSVN $29.82
  • NNNN $5.18
  • 52 Week High
  • BSVN $50.26
  • NNNN $37.08
  • Technical
  • Relative Strength Index (RSI)
  • BSVN 75.78
  • NNNN N/A
  • Support Level
  • BSVN $38.76
  • NNNN N/A
  • Resistance Level
  • BSVN $41.50
  • NNNN N/A
  • Average True Range (ATR)
  • BSVN 1.31
  • NNNN 0.00
  • MACD
  • BSVN 0.46
  • NNNN 0.00
  • Stochastic Oscillator
  • BSVN 92.81
  • NNNN 0.00

About BSVN Bank7 Corp. Common stock

Bank7 Corp is a full-service commercial bank focused on providing customers with exceptional service and meeting their banking needs through a variety of commercial and retail financial services. It offers deposit banking products, including commercial deposit services, commercial checking, money market, and other deposit accounts, and retail deposit services such as certificates of deposit, money market accounts, checking accounts, negotiable order of withdrawal accounts, savings accounts, and automated teller machine access. etc. It generates revenues from interest income from financial instruments and non-interest income and service charges on deposit accounts.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Share on Social Networks: